| Epigenetic therapy inhibits metastases by disrupting premetastatic niches Z Lu, J Zou, S Li, MJ Topper, Y Tao, H Zhang, X Jiao, W Xie, X Kong, ... Nature 579 (7798), 284-290, 2020 | 261 | 2020 |
| Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer Z Lu, H Chen, S Li, J Gong, J Li, J Zou, L Wu, J Yu, W Han, H Sun, X Jiao, ... Journal for immunotherapy of cancer 8 (2), 2020 | 57 | 2020 |
| A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo J Zou, S Li, Z Chen, Z Lu, J Gao, J Zou, X Lin, Y Li, C Zhang, L Shen Cell death & disease 9 (6), 661, 2018 | 44 | 2018 |
| Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer H Liu, C Xu, M Meng, S Li, S Sheng, S Zhang, W Ni, H Tian, Q Wang Acta biomaterialia 144, 132-141, 2022 | 43 | 2022 |
| Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifier Z Lu, H Chen, X Jiao, W Zhou, W Han, S Li, C Liu, J Gong, J Li, X Zhang, ... Journal for immunotherapy of cancer 8 (2), 2020 | 41 | 2020 |
| The role of tissue-resident macrophages in the development and treatment of inflammatory bowel disease S Ma, J Zhang, H Liu, S Li, Q Wang Frontiers in cell and developmental biology 10, 896591, 2022 | 35 | 2022 |
| Serological markers associated with response to immune checkpoint blockade in metastatic gastrointestinal tract cancer Z Lu, J Zou, Y Hu, S Li, T Zhou, J Gong, J Li, X Zhang, J Zhou, M Lu, ... JAMA network Open 2 (7), e197621-e197621, 2019 | 29 | 2019 |
| Baseline derived neutrophil-to-lymphocyte ratio as a prognostic biomarker for non-colorectal gastrointestinal cancer patients treated with immune checkpoint blockade LS Shuang Li, Jianling Zou, Chang Liu, Xi Jiao, Jifang Gong, Jian Li ... Clinical Immunology 108345, 2020 | 22 | 2020 |
| A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer X Jiao, X Wei, S Li, C Liu, H Chen, J Gong, J Li, X Zhang, X Wang, Z Peng, ... NPJ Precision Oncology 5 (1), 36, 2021 | 21 | 2021 |
| Early change in peripheral CD4+ T cells associated with clinical outcomes of immunotherapy in gastrointestinal cancer C Liu, Y Wang, S Li, X Jiao, J Zou, Z Wang, C Qi, X Zhang, J Li, Z Lu, ... Immunotherapy 13 (1), 55-66, 2021 | 16 | 2021 |
| PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients Y Wang, H Chen, X Jiao, L Wu, Y Yang, J Zhang, L Wu, C Liu, N Zhuo, ... Cancer Immunology, Immunotherapy 71 (1), 111-120, 2022 | 13 | 2022 |
| Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer Y Wang, X Jiao, S Li, H Chen, X Wei, C Liu, J Gong, X Zhang, X Wang, ... Cancer Biology & Medicine 19 (8), 1139, 2022 | 8 | 2022 |
| Intestinal delivery of ROS-scavenging carbonized polymer dots for full-course treatment of acute and chronic radiation enteritis J Zhang, M Yang, X Tang, S Li, J Zhang, L Lu, Q Wang, B Yang Applied Materials Today 28, 101544, 2022 | 3 | 2022 |
| Early change in peripheral blood CD4+T cells associated with the clinical outcome in gastrointestinal cancer patients receiving immune checkpoint inhibitors ZH Lu, C Liu, Y Wang, S Li, X Jiao, J Zou, Z Wang, C Qi, X Zhang, J Li, ... Cancer Research 80 (16_Supplement), 3162-3162, 2020 | | 2020 |
| Prediction of immune-checkpoint blockade response in gastrointestinal cancer patients using a machine learning-based RNA signature L Shen, H Zhang, Z Lu, H Chen, X Jiao, W Zhou, S Li, Y Yang, D Liang Cancer Research 80 (16_Supplement), 1563-1563, 2020 | | 2020 |
| A RNA signature predicts outcomes in immune checkpoint blockade treated gastrointestinal cancer patients. Z Lu, H Chen, S Li, X Jiao, L Wu, J Yu, L Shen, H Zhang Journal of Clinical Oncology 37 (15_suppl), e14071-e14071, 2019 | | 2019 |
| Burden of copy number alterations predicts outcomes in immune checkpoint blockade treated gastrointestinal cancer patients. Z Lu, H Chen, S Li, X Jiao, L Wu, H Zhang, L Shen Journal of Clinical Oncology 37 (15_suppl), e14068-e14068, 2019 | | 2019 |
